Research & Development

CEPI is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk. These programmes are part of CEPI’s access-focussed R&D agenda designed to help the world to better prepare for future epidemic and pandemic threats and support progress towards the 100 Days Mission.

A team of scientists working on vaccine creating in a modern laboratory
female scientist holding a pipette looking at equipment

Enabling science

From biological standards to preclinical models, CEPI supports enabling science activities to accelerate development of safe and effective epidemic or pandemic vaccines. Read on to learn about the enabling science activities that CEPI supports.

Read more
2 female scientists writing on a whiteboard in a modern laboratory

Vaccine technology

Vaccines are our most potent weapon against infectious diseases and are at the heart of global responses to epidemic and pandemic threats. 

Read more
A microscopic image of human cells

Calls for Proposals

Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.

Read more
A female scientist from Biofarma holding a vile of vaccine in a lab

Manufacturing and supply chain

CEPI is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.

Read more

Our portfolio

Built on the principles of speed, scale and equitable access, CEPI is supporting the research and development of a diverse portfolio of vaccine candidates based on a range of vaccine approaches.

Find out more
Vaccine vials on a conveyor belt in a manufacturing laboratory